<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Sedgefield 1 PCN</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=pcn+U37593">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Sedgefield 1 PCN is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=1404000AR&amp;denomIds=14.4&amp;selectedTab=summary">Japanese encephalitis vaccine (Inactivated,adsorbed)</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Vaccines and antisera</td>&#13;
      <td>221</td>&#13;
      <td>0.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>35.41</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAADxklEQVR4nO3dv4tcVRjG8e/RQCBgFVxTRB0VbRQE0UgUROtpjIIgCorgdoqIxYA2osVAChNQUYv46z9QBgVFxSoGCViIhRoGGzFF1CKIqHktZorVxnuz75k74/l+mp1d7rz3aR7umbOXOyUikNSGS4YOIGl1LLzUEAsvNcTCSw2x8FJDLLzUEAsvNcTCSw2x8FJDLLzUEAsvrVopg93Pnlb40WQ2ypolqY7MK/w9ibMkVZBZ+NsTZ0mqwMJLDcks/P7RZLYvcZ6kZJmFPw3ckjhPUrLMwp8CDiXOk5Qss/Bf4Od4aa1lFv5L4NbEeZKSpRV+Ph3/Cvw+msy2smZKypV9a63LemmNZRf+FBZeWlvZhf8KuDF5pqQk2YX/HrgueaakJNmFPwtsjSazkjxXUoLUws+n4wB+Aq7InCspR40HYLisl9aUhZcaYuGlhlh4qSEWXmpIjcL/AFxVYa6kXUov/Hw6/hP4bTSZXZY9W9Lu1Houvct6aQ1ZeKkhFl5qiIWXGmLhpYbUKvwZ4NpKsyVdpCqFn0/H54E9fjGFtF5qfl30h8CRivMl9VSz8G8Cj1WcL6mnmoU/CRwYTWbXVDyHpB6qFX759Ju3gUdrnUNSPzWv8ADvAg+PJrNLK59HUgdVCz+fjn8EvgburXkeSd3sWcE5ngdeH01mTwIngHNAABeWP3e+3vm3WEE2aeXmwGgyuztt3nT8WddjS0ROr0op2xHxRsqwFTHzamxa5k3L20fmkn47cdaqmHk1Ni3zpuXtrPamnaQ1YuGlhmQWfhM/85h5NTYt86bl7Sxt007S+nNJLzWk1//hSyl3AXcAZyPiRCnlPhYPuviOxQ02DwE/Ay8DLy7f9mxE/JUXuZ8emd8CjgGvRcTJgeICvTK/BzwAHIiIp4bKC70yvwM8AlwZEU8PlRe6Z46IY6WU24DtiHh8uMS71/cKfzgipsDly9+vj4ijwA3AmEXJ9wI3Ax8BHy9fD6lT5oj4hUXp10HXzGeWx50fKOdOXTOfY1Go/cPE/IdOmUsp+4CbWDzJaaP1Lfy/P/BvwgbA/zpzKeUI8GndOJ10zhwR7wOfl1L21o30n7pmPgRsAXeWUg7WjVRXr0275RLoMIvbY08DV7NYAn0LfAM8yGLZ9grwwvJtz63Bkr5L5leBl4A/gGc2JPMnwFEWDxs5HgPuwPbI/AFwP3AQeCIiLgwSmO6ZI+L48vjJckWwsdyllxriLr3UEAsvNcTCSw2x8FJDLLzUEAsvNcTCSw2x8FJDLLzUEAsvNcTCSw35G0rVRqIqG/RJAAAAAElFTkSuQmCC"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=1404000ARAAAAAA&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Japanese encephalitis vacc (inact, adsorbed) inj 0.5ml pfs : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130S0&amp;denomIds=5.1.13&amp;selectedTab=summary">Fosfomycin calcium</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>3</td>&#13;
      <td>Urinary-tract infections</td>&#13;
      <td>1895</td>&#13;
      <td>0.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>9.16</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130S0AAAAAA&amp;denomIds=5.1.13&amp;selectedTab=summary" target="_blank">Fosfomycin 500mg capsules : 3</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0504010N0&amp;denomIds=5.4.1&amp;selectedTab=summary">Pyrimethamine</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>6</td>&#13;
      <td>Antimalarials</td>&#13;
      <td>1190</td>&#13;
      <td>0.01</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>8.23</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0504010N0AAAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Pyrimethamine 25mg tablets : 6</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0702020T0&amp;denomIds=7.2.2&amp;selectedTab=summary">Nystatin</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>3</td>&#13;
      <td>Vaginal and vulval infections</td>&#13;
      <td>371</td>&#13;
      <td>0.01</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>6.97</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0702020T0AAAFAF&amp;denomIds=7.2.2&amp;selectedTab=summary" target="_blank">Nystatin 100,000unit pessaries : 3</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0107010S0&amp;denomIds=1.7.1&amp;selectedTab=summary">Sucralfate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>4</td>&#13;
      <td>Soothing haemorrhoidal preparations</td>&#13;
      <td>44</td>&#13;
      <td>0.09</td>&#13;
      <td>0.0</td>&#13;
      <td>0.02</td>&#13;
      <td>5.53</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0107010S0AAAKAK&amp;denomIds=1.7.1&amp;selectedTab=summary" target="_blank">Sucralfate 2g/20ml enema : 4</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Sedgefield 1 PCN is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0601021M0&amp;denomIds=6.1.2&amp;selectedTab=summary">Gliclazide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1716</td>&#13;
      <td>Sulfonylureas</td>&#13;
      <td>2841</td>&#13;
      <td>0.60</td>&#13;
      <td>0.93</td>&#13;
      <td>0.11</td>&#13;
      <td>-2.89</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0601021M0AAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 80mg tablets : 1217</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0601021M0AAAMAM&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 30mg modified-release tablets : 5</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0601021M0AAARAR&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 40mg tablets : 476</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0601021M0AAATAT&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 60mg modified-release tablets : 5</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0601021M0AAAVAV&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 160mg tablets : 13</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0410010A0&amp;denomIds=4.10.1&amp;selectedTab=summary">Acamprosate calcium</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Alcohol dependence</td>&#13;
      <td>4</td>&#13;
      <td>0.25</td>&#13;
      <td>0.83</td>&#13;
      <td>0.24</td>&#13;
      <td>-2.45</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0410010A0AAAAAA&amp;denomIds=4.10.1&amp;selectedTab=summary" target="_blank">Acamprosate 333mg gastro-resistant tablets : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130R0&amp;denomIds=5.1.13&amp;selectedTab=summary">Nitrofurantoin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1589</td>&#13;
      <td>Urinary-tract infections</td>&#13;
      <td>1895</td>&#13;
      <td>0.84</td>&#13;
      <td>0.96</td>&#13;
      <td>0.05</td>&#13;
      <td>-2.42</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130R0AAAAAA&amp;denomIds=5.1.13&amp;selectedTab=summary" target="_blank">Nitrofurantoin 50mg capsules : 249</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130R0AAABAB&amp;denomIds=5.1.13&amp;selectedTab=summary" target="_blank">Nitrofurantoin 100mg capsules : 26</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130R0AAACAC&amp;denomIds=5.1.13&amp;selectedTab=summary" target="_blank">Nitrofurantoin 25mg/5ml oral suspension sugar free : 3</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130R0AAADAD&amp;denomIds=5.1.13&amp;selectedTab=summary" target="_blank">Nitrofurantoin 50mg tablets : 237</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130R0AAAEAE&amp;denomIds=5.1.13&amp;selectedTab=summary" target="_blank">Nitrofurantoin 100mg tablets : 68</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0501130R0AAAGAG&amp;denomIds=5.1.13&amp;selectedTab=summary" target="_blank">Nitrofurantoin 100mg modified-release capsules : 1006</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=1311060Q0&amp;denomIds=13.11.6&amp;selectedTab=summary">Potassium permanganate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Oxidisers and dyes</td>&#13;
      <td>2</td>&#13;
      <td>0.50</td>&#13;
      <td>0.93</td>&#13;
      <td>0.20</td>&#13;
      <td>-2.19</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=1311060Q0AAACAC&amp;denomIds=13.11.6&amp;selectedTab=summary" target="_blank">Potassium permanganate 400mg tablets for cutaneous solution : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0403030D0&amp;denomIds=4.3.3&amp;selectedTab=summary">Citalopram hydrobromide</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>4871</td>&#13;
      <td>Selective serotonin re-uptake inhibitors</td>&#13;
      <td>23808</td>&#13;
      <td>0.20</td>&#13;
      <td>0.32</td>&#13;
      <td>0.05</td>&#13;
      <td>-2.17</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0403030D0AAAAAA&amp;denomIds=4.3.3&amp;selectedTab=summary" target="_blank">Citalopram 20mg tablets : 2892</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0403030D0AAABAB&amp;denomIds=4.3.3&amp;selectedTab=summary" target="_blank">Citalopram 10mg tablets : 1376</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U37593&amp;numIds=0403030D0AAACAC&amp;denomIds=4.3.3&amp;selectedTab=summary" target="_blank">Citalopram 40mg tablets : 603</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>